Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer

被引:104
作者
Ryo, A
Uemura, H
Ishiguro, H
Saitoh, T
Yamaguchi, A
Perrem, K
Kubota, Y
Lu, KP
Aoki, I
机构
[1] Yokohama City Univ, Sch Med, Dept Pathol, Kanagawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Sch Med, Dept Urol, Kanagawa Ku, Yokohama, Kanagawa 2360004, Japan
[3] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan
[4] Royal Coll Surgeons Ireland, Oncol Mol Lab, Dublin 2, Ireland
[5] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Biol Program, Boston, MA 02115 USA
关键词
D O I
10.1158/1078-0432.CCR-05-0457
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The peptidyl-prolyl isomrase Pin1 plays a catalytic role in oncogenesis in solid cancers, including prostate cancer. In the present study, we sought to determine the potential of Pin1-targeted gene silencing in inhibiting cellular growth and tumorigenicity in prostate cancer. Experimental Design: A retrovirus-mediated RNA interference targeting Pin1 was expressed in PC3 and LNCaP cells, and cell growth and several transformed properties were investigated. Results: The stable expression of Pin1-specific small interfering RNA constructs in PC3 and LNCaP cells significantly reduced cellular proliferation, colony formation, migration, and invasion but strongly enhanced the apoptotic response induced by serum depletion or treatment with anticancer agents. Furthermore, Pin1 depletion significantly suppressed tumorigenic potential in athymic mice, resulting in the inhibition of both tumor growth and angiogeneisis. Conclusions: These results strongly suggest that Pin1 plays an important role not only in tumorigenesis but also in the maintenance of the transformed phenotype in prostate cancer cells. Hence, Pin1 may serve as a promising therapeutic target, particularly for recurrent prostate tumors.
引用
收藏
页码:7523 / 7531
页数:9
相关论文
共 37 条
[1]   Molecular genetics of prostate cancer [J].
Abate-Shen, C ;
Shen, MM .
GENES & DEVELOPMENT, 2000, 14 (19) :2410-2434
[2]  
Ayala G, 2003, CANCER RES, V63, P6244
[3]   Prevalent overexpression of prolyl isomerase Pin1 in human cancers [J].
Bao, L ;
Kimzey, A ;
Sauter, G ;
Sowadski, JM ;
Lu, KP ;
Wang, DG .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (05) :1727-1737
[4]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[5]   BIOLOGY OF DERMAL WOUND REPAIR [J].
CLARK, RAF .
DERMATOLOGIC CLINICS, 1993, 11 (04) :647-666
[6]   Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment [J].
De Marzo, AM ;
DeWeese, TL ;
Platz, EA ;
Meeker, AK ;
Nakayama, M ;
Epstein, JI ;
Isaacs, WB ;
Nelson, WG .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (03) :459-477
[7]  
DEVARAJAN P, 1992, J BIOL CHEM, V267, P25228
[8]   A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO [J].
DIMRI, GP ;
LEE, XH ;
BASILE, G ;
ACOSTA, M ;
SCOTT, C ;
ROSKELLEY, C ;
MEDRANO, EE ;
LINSKENS, M ;
RUBELJ, I ;
PEREIRASMITH, O ;
PEACOCKE, M ;
CAMPISI, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9363-9367
[9]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[10]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182